DESIGN THERAPEUTICS INC shareholders Q3 2022

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 81 filers reported holding DESIGN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.7%.

DESIGN THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 5,626,476$94,075,00043.01%
Cormorant Asset Management, LP 5,000,000$83,600,0005.84%
Logos Global Management LP 2,797,501$46,774,0005.75%
EcoR1 Capital, LLC 2,519,268$42,122,0001.24%
RA Capital Management 2,773,231$46,368,0000.99%
Avoro Capital Advisors LLC 2,222,222$37,156,0000.69%
Ghost Tree Capital, LLC 100,000$1,672,0000.47%
Integral Health Asset Management, LLC 125,000$2,090,0000.41%
HighVista Strategies LLC 38,152$638,0000.36%
Rock Springs Capital Management LP 460,391$7,698,0000.20%
Tekla Capital Management LLC 280,523$4,690,0000.19%
Ikarian Capital, LLC 48,500$811,0000.16%
Baker Brothers Advisors 1,436,636$24,021,0000.16%
Virtus Investment Advisers, Inc. 14,400$241,0000.11%
Virtus ETF Advisers LLC 7,775$130,0000.05%
EcoR1 Capital, LLC 63,400$1,060,0000.03%
JANUS HENDERSON GROUP PLC 3,007,622$25,170,1450.02%
PRINCIPAL FINANCIAL GROUP INC 819,986$13,710,0000.01%
ExodusPoint Capital Management, LP 51,841$867,0000.01%
TUDOR INVESTMENT CORP ET AL 27,866$466,0000.01%
External links

This page lists DESIGN THERAPEUTICS INC's shareholders in Q3 2022. To view DESIGN THERAPEUTICS INC's shareholder history, click here.